CN106562952B - 氯胺酮在治疗重性抑郁障碍中的应用 - Google Patents
氯胺酮在治疗重性抑郁障碍中的应用 Download PDFInfo
- Publication number
- CN106562952B CN106562952B CN201510648710.XA CN201510648710A CN106562952B CN 106562952 B CN106562952 B CN 106562952B CN 201510648710 A CN201510648710 A CN 201510648710A CN 106562952 B CN106562952 B CN 106562952B
- Authority
- CN
- China
- Prior art keywords
- ketamine
- pharmaceutically acceptable
- acceptable salt
- escitalopram
- major depressive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510648710.XA CN106562952B (zh) | 2015-10-09 | 2015-10-09 | 氯胺酮在治疗重性抑郁障碍中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510648710.XA CN106562952B (zh) | 2015-10-09 | 2015-10-09 | 氯胺酮在治疗重性抑郁障碍中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106562952A CN106562952A (zh) | 2017-04-19 |
CN106562952B true CN106562952B (zh) | 2020-06-09 |
Family
ID=58506448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510648710.XA Active CN106562952B (zh) | 2015-10-09 | 2015-10-09 | 氯胺酮在治疗重性抑郁障碍中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106562952B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115025224A (zh) * | 2017-05-09 | 2022-09-09 | 浙江大学 | T型钙离子通道抑制剂治疗抑郁症的方法和药物 |
CN108853502B (zh) * | 2017-05-09 | 2024-06-14 | 浙江大学 | 治疗抑郁症的方法和药物组合物 |
CN115025227A (zh) * | 2017-05-09 | 2022-09-09 | 浙江大学 | 联合用药治疗抑郁症的方法和药物组合物 |
EP3636281B1 (en) | 2017-05-09 | 2023-11-01 | Zhejiang University | Method for treating depression, and pharmaceutical composition |
ES2907692T3 (es) * | 2017-12-29 | 2022-04-26 | Celon Pharma Sa | Composición de ketamina de polvo seco para su administración por vía pulmonar en la depresión resistente al tratamiento |
PT3908570T (pt) | 2019-01-11 | 2024-03-15 | Alar Pharmaceuticals Inc | Pamoato de cetamina e sua utilização |
CN117338772B (zh) * | 2023-11-22 | 2024-04-09 | 徐州医科大学 | 一种药物组合物及其在制备用于预防和/或治疗重性抑郁障碍的药物中的应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101466364A (zh) * | 2006-03-22 | 2009-06-24 | 纽约大学西奈山医学院 | 鼻内施用氯胺酮治疗抑郁症 |
WO2014143646A1 (en) * | 2013-03-15 | 2014-09-18 | Janssen Pharmaceutica Nv | Pharmaceutical composition of s-ketamine hydrochloride |
WO2014152196A1 (en) * | 2013-03-15 | 2014-09-25 | Janssen Pharmaceutica Nv | Pharmaceutical composition of s-ketamine hydrochloride |
WO2014169272A1 (en) * | 2013-04-12 | 2014-10-16 | Icahn School Of Medicine At Mount Sinai | Method for treating post-traumatic stress disorder |
CN104519878A (zh) * | 2012-03-12 | 2015-04-15 | 詹森药业有限公司 | 用于治疗顽固性或难治性抑郁症的艾氯胺酮 |
-
2015
- 2015-10-09 CN CN201510648710.XA patent/CN106562952B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101466364A (zh) * | 2006-03-22 | 2009-06-24 | 纽约大学西奈山医学院 | 鼻内施用氯胺酮治疗抑郁症 |
CN104519878A (zh) * | 2012-03-12 | 2015-04-15 | 詹森药业有限公司 | 用于治疗顽固性或难治性抑郁症的艾氯胺酮 |
WO2014143646A1 (en) * | 2013-03-15 | 2014-09-18 | Janssen Pharmaceutica Nv | Pharmaceutical composition of s-ketamine hydrochloride |
WO2014152196A1 (en) * | 2013-03-15 | 2014-09-25 | Janssen Pharmaceutica Nv | Pharmaceutical composition of s-ketamine hydrochloride |
WO2014169272A1 (en) * | 2013-04-12 | 2014-10-16 | Icahn School Of Medicine At Mount Sinai | Method for treating post-traumatic stress disorder |
Non-Patent Citations (1)
Title |
---|
氯胺酮在麻醉和治疗抑郁症中的研究进展;古智文 等;《现代生物医药进展》;20121231;第12卷(第33期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN106562952A (zh) | 2017-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106562952B (zh) | 氯胺酮在治疗重性抑郁障碍中的应用 | |
Willis et al. | Fingolimod therapy for multiple sclerosis | |
US20140093592A1 (en) | Esketamine for the treatment of treatment-refractory or treatment-resistant depression | |
JP2013505983A5 (zh) | ||
Corya et al. | A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression | |
KR20220145377A (ko) | 5ht2a 효능제 투여 후의 제어 효과 | |
CN111032089A (zh) | 用于治疗应激相关障碍的组合物 | |
US11813247B2 (en) | NK-1 antagonist compositions and methods for use in treating depression | |
JP2020128391A (ja) | Nmda調節剤を使用するうつ病の治療方法 | |
RU2268725C2 (ru) | Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств | |
JP2024511066A (ja) | 不適応ストレス応答から生じる疾患を治療する改善された方法 | |
Ahmed et al. | Ketamine versus fentanyl as an adjuvant to local anesthetics in the peribulbar block for vitreoretinal surgeries: randomized controlled study | |
CA3203144A1 (en) | Dosage regimen for a nr2b-nmda receptor nam for the treatment of depression | |
JP2020517670A (ja) | うつ病を治療するための組成物および方法 | |
KR20190025556A (ko) | 항우울 효과의 신속한 개시를 위한 보티옥세틴 투여 요법 | |
AU2018290889B2 (en) | NK-1 antagonist compositions and methods for use in treating depression | |
Quinones | IV ketamine infusions for the treatment of depression: An evidence based practice analysis | |
WO2024102696A1 (en) | Uses of bupivacaine multivesicular liposomes as stellate ganglion block for treating anxiety disorders and traumatic brain injury | |
Kielholz | Treatment of therapy-resistant depression with drip infusions | |
KR20220021443A (ko) | 우울증 치료를 위한 돔페리돈 조성물 및 방법 | |
Smith Jr | Individualizing premedication. | |
ULC et al. | PrMYLAN-FINGOLIMOD | |
DEPRESSIONS | TREATMENT OF THERAPY-RESISTANT DEPRESSION WITH DRIP INFUSIONS | |
Class et al. | Patent application title: TREATMENT OF MULTIPLE SCLEROSIS WITH MASITINIB Inventors: Alain Moussy (Paris, FR) Alain Moussy (Paris, FR) Jean-Pierre Kinet (Lexington, MA, US) Jean-Pierre Kinet (Lexington, MA, US) Assignees: AB SCIENCE | |
KR20130020944A (ko) | 골수이형성 증후군을 치료하기 위한 조성물 및 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200508 Address after: 214400 floor 3-5, unit 3, building A4, No. 2, Dongsheng West Road, Chengdong street, Jiangyin City, Wuxi City, Jiangsu Province Applicant after: JIANGYIN AMBER BIOPHARMACEUTICAL Co.,Ltd. Applicant after: Liu Qi Address before: 100081 Beijing city Haidian District xicaochang No. six room 6002 Applicant before: BEIJING ANPO TECHNOLOGY Co.,Ltd. Applicant before: BEIJING ZHIYUAN TECHNOLOGY Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Gang Inventor after: Yan Jingbo Inventor after: Xiang Yutao Inventor after: Hu Yongdong Inventor before: Wang Gang Inventor before: Chen Guang Inventor before: Yan Jingbo Inventor before: Xiang Yutao Inventor before: Hu Yongdong |